{
  "0": {
    "uuid": "5da2cd2a-4844-3724-8651-82ea46adb603",
    "title": "Insider Sell: EVP, Chief Business/Strategy Officer Nicholas Donoghoe Sells 21,082 Shares of ...",
    "publisher": "GuruFocus.com",
    "link": "https://finance.yahoo.com/news/insider-sell-evp-chief-business-230039844.html",
    "providerPublishTime": 1711148439,
    "type": "STORY",
    "thumbnail": {
      "resolutions": [
        {
          "url": "https://s.yimg.com/uu/api/res/1.2/Cw_VBIHQ_Ty_vnYjEHm5_g--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/722744eb178bf9fd087628cc78b1086b",
          "width": 1242,
          "height": 543,
          "tag": "original"
        },
        {
          "url": "https://s.yimg.com/uu/api/res/1.2/dbhG2xeWNGAl.2syTjhztw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/722744eb178bf9fd087628cc78b1086b",
          "width": 140,
          "height": 140,
          "tag": "140x140"
        }
      ]
    },
    "relatedTickers": [
      "ABBV"
    ]
  },
  "1": {
    "uuid": "95466027-76b5-3822-b98d-93ad2ef13fc9",
    "title": "UPDATE 1-US FDA grants full approval to AbbVie's ovarian cancer therapy",
    "publisher": "Reuters",
    "link": "https://finance.yahoo.com/news/1-us-fda-grants-full-191053529.html",
    "providerPublishTime": 1711134653,
    "type": "STORY",
    "relatedTickers": [
      "ABBV"
    ]
  },
  "2": {
    "uuid": "dd1cbbb3-3a1f-3891-b0cb-39e52bfe32cf",
    "title": "U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE\u00ae (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients",
    "publisher": "PR Newswire",
    "link": "https://finance.yahoo.com/news/u-food-drug-administration-fda-190200273.html",
    "providerPublishTime": 1711134120,
    "type": "STORY",
    "thumbnail": {
      "resolutions": [
        {
          "url": "https://s.yimg.com/uu/api/res/1.2/.Xe1EIX7J6bie9vkkSC.wQ--~B/aD03MDt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/a5eaa0af5f515703fe951de405417559",
          "width": 400,
          "height": 70,
          "tag": "original"
        },
        {
          "url": "https://s.yimg.com/uu/api/res/1.2/emZzkY5ITA.loqGcgSlrjw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a5eaa0af5f515703fe951de405417559",
          "width": 140,
          "height": 140,
          "tag": "140x140"
        }
      ]
    },
    "relatedTickers": [
      "ABBV"
    ]
  },
  "3": {
    "uuid": "5db1b248-967e-3c7e-a1b2-a26581bb29ec",
    "title": "US FDA grants full approval to AbbVie's ovarian cancer therapy",
    "publisher": "Reuters",
    "link": "https://finance.yahoo.com/news/us-fda-grants-full-approval-183525861.html",
    "providerPublishTime": 1711132525,
    "type": "STORY",
    "relatedTickers": [
      "ABBV"
    ]
  },
  "4": {
    "uuid": "3283639e-cc7b-32cf-bb95-4e4a6099f27f",
    "title": "11 Best Healthcare ETFs To Buy Now",
    "publisher": "Insider Monkey",
    "link": "https://finance.yahoo.com/news/11-best-healthcare-etfs-buy-142503468.html",
    "providerPublishTime": 1711031103,
    "type": "STORY",
    "thumbnail": {
      "resolutions": [
        {
          "url": "https://s.yimg.com/uu/api/res/1.2/RZQ4ZrVa6rbvpYzIFrc0.Q--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/67e507f79916ae4e3b975fb95c3b2215",
          "width": 768,
          "height": 430,
          "tag": "original"
        },
        {
          "url": "https://s.yimg.com/uu/api/res/1.2/NUBsmCF3hMmxa9hCYWUXUw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/67e507f79916ae4e3b975fb95c3b2215",
          "width": 140,
          "height": 140,
          "tag": "140x140"
        }
      ]
    },
    "relatedTickers": [
      "LLY",
      "JNJ",
      "NTRA",
      "MRK",
      "ABT",
      "UNH",
      "ABBV",
      "TMO",
      "DHR"
    ]
  },
  "5": {
    "uuid": "48a23ced-69f9-3c24-bf40-8da6912d98a8",
    "title": "16 Best Passive Income Stocks To Buy According to Hedge Funds",
    "publisher": "Insider Monkey",
    "link": "https://finance.yahoo.com/news/16-best-passive-income-stocks-140023724.html",
    "providerPublishTime": 1711029623,
    "type": "STORY",
    "thumbnail": {
      "resolutions": [
        {
          "url": "https://s.yimg.com/uu/api/res/1.2/Gi5L3S49LGxqTv.eHTqzQg--~B/aD0xMjc1O3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/49de360447d6c3bc2d07313db7578ad2",
          "width": 1920,
          "height": 1275,
          "tag": "original"
        },
        {
          "url": "https://s.yimg.com/uu/api/res/1.2/nCD0k483atoARoYCbcafRg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/49de360447d6c3bc2d07313db7578ad2",
          "width": 140,
          "height": 140,
          "tag": "140x140"
        }
      ]
    },
    "relatedTickers": [
      "QCOM",
      "CVX",
      "JNJ",
      "ABBV",
      "HD",
      "^GSPC",
      "AVGO",
      "PM",
      "PG",
      "LOW",
      "NKE"
    ]
  },
  "6": {
    "uuid": "8cb2acf2-7b57-33d5-bfa6-ab473c9c73a0",
    "title": "ALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY, DRIVE INNOVATION AND LEAD WITH INTEGRITY AS IT HOSTS EXPERT LED SYMPOSIA AT AMWC 2024",
    "publisher": "PR Newswire",
    "link": "https://finance.yahoo.com/news/allergan-aesthetics-continues-champion-individuality-120000385.html",
    "providerPublishTime": 1711022400,
    "type": "STORY",
    "thumbnail": {
      "resolutions": [
        {
          "url": "https://s.yimg.com/uu/api/res/1.2/EB0Nj3iAGenecZHgjW_6TQ--~B/aD05Nzt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/d07e572eaef73a27c1ae25977c221fa1",
          "width": 400,
          "height": 97,
          "tag": "original"
        },
        {
          "url": "https://s.yimg.com/uu/api/res/1.2/_CLNRpoGaJZdxrGyZ9D7xQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/d07e572eaef73a27c1ae25977c221fa1",
          "width": 140,
          "height": 140,
          "tag": "140x140"
        }
      ]
    },
    "relatedTickers": [
      "ABBV"
    ]
  },
  "7": {
    "uuid": "bc875a25-e8bd-3079-94ff-8974721252e7",
    "title": "The Zacks Analyst Blog Highlights Mastercard, AbbVie, Salesforce, Thermo Fisher Scientific and Mondelez",
    "publisher": "Zacks",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-mastercard-094800007.html",
    "providerPublishTime": 1710928080,
    "type": "STORY",
    "thumbnail": {
      "resolutions": [
        {
          "url": "https://s.yimg.com/uu/api/res/1.2/ExUW7WdnJLzGBIF0zM.lsw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1b40eb5468b4169ccaae74a0c512c12d",
          "width": 635,
          "height": 400,
          "tag": "original"
        },
        {
          "url": "https://s.yimg.com/uu/api/res/1.2/zZsVULDVlkHC3NsWgqOa0Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/1b40eb5468b4169ccaae74a0c512c12d",
          "width": 140,
          "height": 140,
          "tag": "140x140"
        }
      ]
    },
    "relatedTickers": [
      "ABBV",
      "MA",
      "TMO",
      "CRM"
    ]
  }
}